TXNIP Inhibition and Retinal Cell Survival in Glaucoma
Author Information
Author(s): Chen Junjue, Zhong Huimin, Shen Bingqiao, Yu Huan, Zhang Yang, Han Ruiqi
Primary Institution: Ruijin Hospital Affiliated Medical School, Shanghai Jiaotong University
Hypothesis
TXNIP plays a role in retinal ganglion cell survival and microglial transformation in glaucoma.
Conclusion
Inhibiting TXNIP promotes retinal ganglion cell survival and alters microglial activation in glaucoma.
Supporting Evidence
- TXNIP expression was significantly increased in glaucomatous retinas.
- Ablation of TXNIP promoted retinal ganglion cell survival.
- TXNIP knockout reduced proinflammatory cytokine secretion in microglia.
- TXNIP mediates microglial activation in response to high pressure.
- TXNIP inhibition enhanced glucose uptake in microglia.
- IL-17A was found to interact with TXNIP in regulating microglial transformation.
- TXNIP affects microglial polarization via the PI3K/Akt signaling pathway.
Takeaway
This study shows that blocking a protein called TXNIP helps protect eye cells in glaucoma and changes how certain immune cells behave.
Methodology
The study used chronic ocular hypertension mice models and various assays including Western blot, RT-PCR, and immunofluorescence to assess retinal inflammation and cell survival.
Participant Demographics
Male wild-type and TXNIP knockout mice, aged 6-8 weeks.
Statistical Information
P-Value
0.00
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website